The first ever drug available for treating acute onset pancreatitis in dogs, Panoquell-CA1 (fuzapladib sodium), just received conditional approval by CVM. Sponsored by Ishihara Sangyo Kaisha, Ltd, KFI carried out the TASS for this injectable drug. “It is so exciting that we were part of the new drug discovery to treat such a serious illness in dogs” said Dr. Vicki Langford DVM and KFI’s Study Director for the pivotal safety study. “Prior to this, veterinarians could only treat this disease with supportive care. Having a drug is going to make such a difference to dogs suffering from this illness.”

FDA Conditionally Approves First Drug to Manage Acute Onset of Pancreatitis in Dogs | FDA
Nov 15, 2022